 |
 |
||||||
 |
Our customers' Feedback |
Your cart
$0.00 (0 items)
| |||||
Generic Montelukast - Singulair
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Our billing is certified by:
- Can Montelukast Reduce the Frequency of URTI in Children? - Medscape
Can Montelukast Reduce the Frequency of URTI in Children?MedscapeMontelukast selectively inhibits leukotriene receptors, thereby limiting the ability of leukotrienes to trigger inflammation.
- Major Pharmaceuticals Prepare Themselves for Patent Expirations in 2012 - MarketWatch (press release)
Major Pharmaceuticals Prepare Themselves for Patent Expirations in 2012MarketWatch (press release)Merck's worldwide sales of SINGULAIR (montelukast sodium), a once-a-day oral medicine for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, grew 1 percent from the first quarter of 2011 to $1.
- Asthma drugs: What every parent should know - Philadelphia Inquirer
Philadelphia InquirerAsthma drugs: What every parent should knowPhiladelphia InquirerAnother preventive asthma medicationis Montelukast (Singulair), a pill taken at night that also helps nasal stuffiness.
- Loopholes in pharma pricing policy - Hindu Business Line
Hindu Business LineLoopholes in pharma pricing policyHindu Business LineAmong drugs used in asthma we have salbutamol and the rarely used ipratropium, whereas other frequently used drugs in asthma such as terbutaline, salmeterol, formeterol, bambuterol, theophylline, doxofylline, montelukast and zafirlukast will be out of .
- Strong profit growth and Zetia patent win for Merck & Co - Pharma Times
Strong profit growth and Zetia patent win for Merck & CoPharma TimesMerck's best-selling treatment was once again the asthma/allergic rhinitis drug Singulair (montelukast), which inched up 1% to $1.
|
|
Copyright © 2005-2012 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy. www.canadianpharmacyonline.biz is an affiliate marketing website |